|
|
Other links at Articles > Ophthalmology |
| 3. |
Rosiglitazone May Preserve Vision in Diabetic Retinopathy
|
|
|
Rosiglitazone (Avandia, GlaxoSmithKline) may slow the progression of diabetic retinopathy and preserve vision by reducing retinal neovascularization, physicians at Harvard Medical School in Boston report in the June Archives of Ophthalmology. Reuters Health Information
|
|
|